PC
USNA icon

Palo Capital’s Usana Health Sciences USNA Stock Holding History

Palo Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,084
Closed -$394K – 199
2016
Q2 		$394K Buy
+7,084
New +$427K 0.14% 164

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Palo Capital's USNA Position: Q3 2016 in Review

Palo Capital sold out of Usana Health Sciences (USNA) in Q3 2016, closing a stake of 7,084 shares — an estimated $394K sold.

Palo Capital first reported a position in USNA in Q2 2016 and held it in 1 quarter. The position peaked at $394K in Q2 2016. 140 funds tracked by Wall St. Rank hold USNA as of Q3 2016.

  • Palo Capital reported no remaining Usana Health Sciences position as of Q3 2016 after selling out during the quarter.
  • Palo Capital sold 7,084 Usana Health Sciences shares in Q3 2016, an estimated $394K.
  • Palo Capital first reported a position in Usana Health Sciences in Q2 2016 and held it in 1 quarter.
  • Palo Capital's Usana Health Sciences position peaked at $394K in Q2 2016.
  • 140 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2016.

Based on Palo Capital's 13F filing for Q3 2016, filed 20 Oct 2016.